Impact of Immune-related Adverse Events on Nivolumab Efficacy in Patients With Upper Gastrointestinal Cancer

Background: The development of immune-related adverse events (irAEs) has been found to be associated with survival benefits in some cancers. However, data on the relation between irAEs and gastroesophageal adenocarcinoma (GEA) or esophageal squamous cell carcinoma (ESCC) are scarce. Patients and Met...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:In Vivo
Egile Nagusiak: BOOKA, EISUKE, KIKUCHI, HIROTOSHI, HANEDA, RYOMA, SONEDA, WATARU, KAWATA, SANSHIRO, MURAKAMI, TOMOHIRO, MATSUMOTO, TOMOHIRO, HIRAMATSU, YOSHIHIRO, TAKEUCHI, HIROYA
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Institute of Anticancer Research 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286467/
https://ncbi.nlm.nih.gov/pubmed/34182512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12506
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak